论文信息 - Galactonojirimycin derivatives restore mutant human β-galactosidase activities expressed in fibroblasts from enzyme-deficient knockout mouse - 字舞流文

Galactonojirimycin derivatives restore mutant human β-galactosidase activities expressed in fibroblasts from enzyme-deficient knockout mouse

Yoshiyuki Suzuki | J. Matsuda | E. Nanba | A. Oshima | K. Ohno | Y. Ogawa | Lika Tominaga | Megumi Taniguchi

[1] V. Perry,et al. Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[2] V. Perry,et al. Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin. , 1997, Science.

[3] Yoshiyuki Suzuki,et al. Neurological manifestations of knockout mice with β-galactosidase deficiency , 1997, Brain and Development.

[4] Suzuki Yoshiyuki,et al. Galactosialidosis (β-galactosidase-neuraminidase deficiency): a possible role of serine-thiol proteases in the degradation of β-galactosidase molecules , 1982 .

[5] Satoshi Ishii,et al. Accelerated transport and maturation of lysosomal α–galactosidase A in Fabry lymphoblasts by an enzyme inhibitor , 1999, Nature Medicine.